176 related articles for article (PubMed ID: 19859983)
1. Metal ionophores - an emerging class of anticancer drugs.
Ding WQ; Lind SE
IUBMB Life; 2009 Nov; 61(11):1013-8. PubMed ID: 19859983
[TBL] [Abstract][Full Text] [Related]
2. Pyrithione and 8-hydroxyquinolines transport lead across erythrocyte membranes.
Lind SE; Park JS; Drexler JW
Transl Res; 2009 Sep; 154(3):153-9. PubMed ID: 19665691
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of the antibiotic clioquinol.
Ding WQ; Liu B; Vaught JL; Yamauchi H; Lind SE
Cancer Res; 2005 Apr; 65(8):3389-95. PubMed ID: 15833873
[TBL] [Abstract][Full Text] [Related]
5. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
6. Clioquinol targets zinc to lysosomes in human cancer cells.
Yu H; Zhou Y; Lind SE; Ding WQ
Biochem J; 2009 Jan; 417(1):133-9. PubMed ID: 18764784
[TBL] [Abstract][Full Text] [Related]
7. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
8. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
[TBL] [Abstract][Full Text] [Related]
9. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.
Di Vaira M; Bazzicalupi C; Orioli P; Messori L; Bruni B; Zatta P
Inorg Chem; 2004 Jun; 43(13):3795-7. PubMed ID: 15206857
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis.
Chen M; Ding Y; Ke Y; Zeng Y; Liu N; Zhong Y; Hua X; Li Z; Xiong Y; Wu C; Yu H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):824-833. PubMed ID: 32456481
[TBL] [Abstract][Full Text] [Related]
11. Pyrithione, a zinc ionophore, inhibits NF-kappaB activation.
Kim CH; Kim JH; Moon SJ; Chung KC; Hsu CY; Seo JT; Ahn YS
Biochem Biophys Res Commun; 1999 Jun; 259(3):505-9. PubMed ID: 10364448
[TBL] [Abstract][Full Text] [Related]
12. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
[TBL] [Abstract][Full Text] [Related]
13. Retro hydrazino-azapeptoids as peptidomimetics of proteasome inhibitors.
Aubin S; Martin B; Delcros JG; Arlot-Bonnemains Y; Baudy-Floc'h M
J Med Chem; 2005 Jan; 48(1):330-4. PubMed ID: 15634028
[TBL] [Abstract][Full Text] [Related]
14. A categorization of metal anticancer compounds based on their mode of action.
Gianferrara T; Bratsos I; Alessio E
Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
[TBL] [Abstract][Full Text] [Related]
15. Novel organic proteasome inhibitors identified by virtual and in vitro screening.
Basse N; Montes M; Maréchal X; Qin L; Bouvier-Durand M; Genin E; Vidal J; Villoutreix BO; Reboud-Ravaux M
J Med Chem; 2010 Jan; 53(1):509-13. PubMed ID: 19919035
[TBL] [Abstract][Full Text] [Related]
16. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
17. The role of proteasome in malignant diseases.
Moran E; Nencioni A
J BUON; 2007 Sep; 12 Suppl 1():S95-9. PubMed ID: 17935285
[TBL] [Abstract][Full Text] [Related]
18. Heavy metals and lysosomes.
Sternlieb I; Goldfischer S
Front Biol; 1976; 45():185-200. PubMed ID: 789127
[TBL] [Abstract][Full Text] [Related]
19. Metals and cellular signaling in mammalian cells.
DeMoor JM; Koropatnick DJ
Cell Mol Biol (Noisy-le-grand); 2000 Mar; 46(2):367-81. PubMed ID: 10774926
[TBL] [Abstract][Full Text] [Related]
20. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
